Idiopathic third and sixth cranial nerve neuritis

Abstract

Purpose To present cases with idiopathic third and sixth cranial nerve neuritis. Study design Retrospective observational study Methods The results of high resolution pre-and post-cranial nerve magnetic resonance images (MRI) with three-dimensional sequences for visualizing cranial nerves in patients with third, fourth, and sixth cranial nerve palsies who were treated at the Neuro-ophthalmology Department of Samsung Medical Center were reviewed. Patients with cranial nerve enhancement confirmed by experienced radiologists were identified. The medical records of these patients were reviewed, and their demographics, clinical presentations, laboratory results, and clinical outcomes were analyzed. Results Of 265 patients with third, fourth, and sixth cranial nerve palsy, 60 were identified by high resolution MRI as having enhancement of the corresponding cranial nerve. Among these, 17 patients with infiltrative, granulomatous, or tumorous lesions were excluded. In addition, 28 patients with identifiable causes of cranial nerve palsy, such as Miller-fisher syndrome, virus infection, or radiation-induced neuropathy, as well as patients with vasculopathic risk factors, were also excluded. Ultimately, a total of 15 patients with idiopathic third and sixth cranial nerve neuritis were included in this study. The mean age of these patients was 43 ± 15 years. Eight patients had sixth cranial nerve palsy, six third cranial nerve palsy (two partial and four complete), and one patient with complete third and sixth cranial nerve palsy. Nine patients received steroid treatment. Eleven patients recovered fully within a period ranging from a few days to one year. Two patients were much improved up to 1 month after initial presentation, but were then ultimately lost to follow-up. Another patient was lost to follow-up after the initial work-up. The other patient lost to follow-up had partially recovered during the first 6 months. Conclusions We present patients with idiopathic third and sixth cranial nerve neuritis. They tended to respond well to steroid treatment and to have good prognoses. In order to better understand the long-term prognosis of cranial nerve neuritis and possible association with other neurologic disorders, a larger scale and longer-term study is needed.

Diplopia outcomes following stereotactic radiosurgery for petroclival or cavernous sinus meningiomas: patient series

“…Those who received steroid treatment responded well and were deemed to have the best prognosis of those in the sample, leading authors to believe that steroid treatment is an effective therapy, at least temporarily, for idiopathic CN VI dysfunction. 15 …”

Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events

“…Cranial nerve palsy caused by neuritis is characterized by thickening and post-contrast enhancement, shown under high-resolution MRI [ 15 ]. The abducens nerve is the sixth cranial nerve.…”

Cranial polyneuritis in a dog: Presentation, diagnosis, treatment and outcome

“…All of these drugs cross the blood‐brain barrier, and as ciclosporin does not, perhaps these drugs may have been a better choice in this case. In human medicine, steroid therapy alone is used to treat idiopathic cranial polyneuritis; however, there is a paucity in the literature to offer specific recommended protocols 3,4,18 . Cases of cranial polyneuropathy in humans can be self‐limiting, steroids result in a rapid amelioration of signs; however, the literature is contradictory when describing whether steroid therapy can hasten resolution of cranial nerve deficits 3–5 .…”